Dr. Nathan Johnson, Ph.D. is thePresident & CEO of Verne Bioanalytics. He has a hybrid of microbiology, molecular biology, and bioinformatics expertise across 15 years for food testing, oncology, immunology, stem cell biology, animal model development, and plant-related efforts. He has published peer-review scientific papers including in prestigious journals such as Nature, Cell, and Science, and held positions such as Dana Farber Cancer Institute, Harvard Medical School, Takeda, H3 Biomedicine, and Mouse and Rat Resource Centers. He holds a Ph.D. in Bioinformatics & Computational Biology, MS in Biomedical Sciences, and a BS in biology and minor in chemistry.